Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study

Saved in:
Bibliographic Details
Published in:Immunotherapy Advances
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553705075245056
collection WordPress RSS
FRELIP Feed Integration
container_title Immunotherapy Advances
description
discipline_display Allergology and Immunology
discipline_facet Allergology and Immunology
format Online Article
RSS Article
genre Journal Article
id rss_article:84514
institution FRELIP
journal_source_facet Immunotherapy Advances
last_indexed 2026-06-20T21:41:14.952Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
Allergology and Immunology
General
Allergology and Immunology
sub_discipline_display General
sub_discipline_facet General
subject_display Allergology and Immunology
General
Allergology and Immunology
subject_facet Allergology and Immunology
General
Allergology and Immunology
title Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
title_alt Supervivencia general según el índice de inflamación inmune sistémica basal y durante el tratamiento en pacientes con cáncer avanzado que reciben inhibidores de puntos de control inmunitarios: un gran estudio de cohorte unicéntrico
Survie globale selon l'indice d'inflammation immunitaire systémique de base et en cours de traitement chez les patients atteints de cancer avancé recevant des inhibiteurs de points de contrôle immunitaires : une grande étude de cohorte monocentrique
Sobrevida global por índice de inflamação imune sistêmico basal e durante o tratamento em pacientes com câncer avançado recebendo inibidores de checkpoint imune: um grande estudo de coorte de centro único
title_auth Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
title_es_txt Supervivencia general según el índice de inflamación inmune sistémica basal y durante el tratamiento en pacientes con cáncer avanzado que reciben inhibidores de puntos de control inmunitarios: un gran estudio de cohorte unicéntrico
title_fr_txt Survie globale selon l'indice d'inflammation immunitaire systémique de base et en cours de traitement chez les patients atteints de cancer avancé recevant des inhibiteurs de points de contrôle immunitaires : une grande étude de cohorte monocentrique
title_full Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
title_fullStr Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
title_full_unstemmed Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
title_pt_txt Sobrevida global por índice de inflamação imune sistêmico basal e durante o tratamento em pacientes com câncer avançado recebendo inibidores de checkpoint imune: um grande estudo de coorte de centro único
title_short Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
title_sort overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study
topic Allergology and Immunology
General
Allergology and Immunology
url https://academic.oup.com/immunotherapyadv/article/doi/10.1093/immadv/ltaf031/8550800?rss=1